Um zukunftsfähig zu sein, wurde unsere aktuelle Webseite für die neuesten Technologien entwickelt. Daher können bei alten Browsern leider Probleme auftreten.
Damit die neue Börse-Online-Seite richtig funktioniert und Spaß macht, empfehlen wir Ihnen einen dieser aktuellen und kostenlosen Browser herunterzuladen:
Und heut wieder hoch und morgen wieder 38,34 % runter.. Lasst euch nich verarschen.. Am Ende könnt ihr froh sein in D nich mehr handeln zu können.. Und lasst euch nich von Blinden blenden.. Erst recht nicht von gehenden..
: Ach was soll,s. Mal hoch mal runter. ch ziehe mich
jetzt mal ein wenig zurück hier. Ständiges Posten bringt ja eh nichts... Ich halte meine Anteile long und freue mich (hoffentlich!!!) Ende 2012 über schöne Kursgewinne. Dann lass ich die Amis jetzt mal machen...
WEST PALM BEACH, Fla., Feb. 21, 2012 /PRNewswire/ -- SurgLine International, Inc. (SGLN.PK).
Thomas Toland, CEO of SGLN and SurgLine, Inc. ("SurgLine") stated, "Over the past six months we have made certain public relations announcements as to certain strategic business arrangements, distribution contracts and a pending acquisition in an effort to update our shareholders of the company's continued progress.
Our management team has completed an internal review of each of the previously made announcements and continues to believe at this date that each announcement previously released still merits continued revenue opportunities for the Company through the end of calendar year 2012 and beyond."
In addition Mr. Toland was quoted as saying, "The Company is working to develop long-term business solutions in the acute care healthcare space and in the operating room. In some cases these opportunities may take longer than expected to integrate our high value, low cost solutions into our intended client product offerings. It is not unusual for acute care hospital systems to move slowly even when they wish to move quickly. We remain focused on developing long-term clients who benefit from our product offerings, including spine hardware, trauma, and sports medicine."
Finally, Mr. Toland also was quoted as saying, "We are committed to keeping our shareholders apprised of any material events as they occur and which we are focused on achieving each and every day. Additionally, we are committed to identifying and improving any element or issue that may prevent us from reaching our collective goals as a Company. This will include selecting highly competent and seasoned independent board members that will add confidence and expertise to our team. Long-term strategies include revenue and earnings growth, and expansion of our business model into new markets where appropriate and reporting our results on an ongoing basis via regulatory disclosure at all times."
About SurgLine, Inc.
SurgLine (www.surgline.com) sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospital, self insured employers and insurance companies. SurgLine offers high quality medical and surgical supplies and products at substantial savings utilizing stocking distributors and institutional buyers by sourcing products globally without the historical brand premium and industry markup.
About SurgLine International, Inc.
SurgLine International, Inc. is a holding company that in addition to SurgLine, wholly owns Nuvo Solar Energy, Inc., a development stage company that owns unique patent pending solar and photovoltaic related technology. The Company is also seeking other business opportunities.
This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.
For Further Information Contact: Thomas Toland 949-698-8485
* Deutsche Bank Real-Time Indikationen basieren auf Preisen von der Deutschen Bank emittierten Produkten. Diese Produkte versuchen, den jeweiligen Index 1:1 zu tracken.
Die Preisstellung erfolgt börsentäglich zwischen 09:15 und 17:15.